Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TROP2 overexpression
i
Other names:
TROP2, Trophoblast Cell Surface Antigen 2, Tumor Associated Calcium Signal Transducer 2, Membrane Component Chromosome 1 Surface Marker 1, Tumor-Associated Calcium Signal Transducer 2, Pancreatic Carcinoma Marker Protein GA733-1, Cell Surface Glycoprotein Trop-2, Epithelial Glycoprotein-1, GA733-1, M1S1, Gastrointestinal Tumor-Associated Antigen GA733, Pancreatic Carcinoma Marker Protein GA7331, Cell Surface Glycoprotein TROP2, Truncated TACSTD2, GA7331, EGP-1, GP50 , TACSTD2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TROP2 overexpression
Non Small Cell Lung Cancer
TROP2 overexpression
Non Small Cell Lung Cancer
datopotamab deruxtecan
Sensitive: C3 – Early Trials
datopotamab deruxtecan
Sensitive
:
C3
datopotamab deruxtecan
Sensitive: C3 – Early Trials
datopotamab deruxtecan
Sensitive
:
C3
TROP2 overexpression
Triple Negative Breast Cancer
TROP2 overexpression
Triple Negative Breast Cancer
MK-2870
Sensitive: C3 – Early Trials
MK-2870
Sensitive
:
C3
MK-2870
Sensitive: C3 – Early Trials
MK-2870
Sensitive
:
C3
TROP2 overexpression
Triple Negative Breast Cancer
TROP2 overexpression
Triple Negative Breast Cancer
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
sacituzumab govitecan-hziy
Sensitive
:
D
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
sacituzumab govitecan-hziy
Sensitive
:
D
TROP2 overexpression
Triple Negative Breast Cancer
TROP2 overexpression
Triple Negative Breast Cancer
BAT8003
Sensitive: D – Preclinical
BAT8003
Sensitive
:
D
BAT8003
Sensitive: D – Preclinical
BAT8003
Sensitive
:
D
TROP2 overexpression
Endometrial Cancer
TROP2 overexpression
Endometrial Cancer
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
sacituzumab govitecan-hziy
Sensitive
:
D
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
sacituzumab govitecan-hziy
Sensitive
:
D
TROP2 overexpression
Breast Cancer
TROP2 overexpression
Breast Cancer
datopotamab deruxtecan
Sensitive: D – Preclinical
datopotamab deruxtecan
Sensitive
:
D
datopotamab deruxtecan
Sensitive: D – Preclinical
datopotamab deruxtecan
Sensitive
:
D
TROP2 overexpression
Pancreatic Cancer
TROP2 overexpression
Pancreatic Cancer
hIMB1636-MMAE
Sensitive: D – Preclinical
hIMB1636-MMAE
Sensitive
:
D
hIMB1636-MMAE
Sensitive: D – Preclinical
hIMB1636-MMAE
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
